Wearable Injectors Market Growth, Demand and Challenges of the Key Industry Players 2024-2032

The global wearable injectors market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.4 Billion by 2032, exhibiting a growth rate (CAGR) of 13.4% during 2024-2032.

More Info:- https://www.imarcgroup.com/wearable-injectors-market

1. Global Wearable Injectors Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved

2. About IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Highlight and Description According to the latest report by IMARC Group, titled  "Wearable Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,"  the  global wearable injectors market size reached US$ 7.7 Billion in 2023. Wearable injectors (WIs) or patch pumps are drug delivery devices utilized for the single-step administration of medicines for longer durations. They automatically deliver preset doses to patients at optimal times. They are temporarily attached to the skin to deliver viscous drugs in large volumes faster and safely through the subcutaneous tissues in the body. They comprise a cannula for substance delivery to tissues, a reservoir to store medicine, and a drive system to provide the appropriate drug volume. In addition, these devices are user-friendly, disposable, and cause minimal discomfort and pain compared to traditionally used syringes and vials. As a result, wearable injectors are extensively used for the treatment of diabetes, rheumatoid arthritis, cancer, and cardiovascular diseases. Request for a PDF sample of this report: https://www.imarcgroup.com/wearable-injectors-market/requestsample

4. Report Description Global Wearable Injectors Market Trends : The market is primarily driven by the increasing prevalence of chronic medical illnesses such as neurological, oncological, and autoimmune disorders. In addition, the rising geriatric population, which is more susceptible to such ailments, and the escalating demand for minimally invasive (MI) treatment alternatives among the patients represent other major growth-inducing factors. Moreover, the sudden outbreak of the coronavirus disease (COVID-19) pandemic prompted the entire healthcare system to switch to home-based therapies to stop the spread of the sickness. This, coupled with the growing popularity of at-home and self-administrable injectors to effectively manage disorders with the minutest risks of inaccurate dosage and needle stick injuries, is providing a positive thrust to the market growth. Besides this, various product innovations, such as the incorporation of wireless connectivity, passive warning systems, and Bluetooth technologies with the injectors, are anticipated to propel the market growth. These technologies promote convenient monitoring of the patient through a smartphone application and offer timely reminders for dosages. Furthermore, extensive research and development (R&D) activities, along with significant improvements in the healthcare infrastructure, are creating a positive market outlook. Looking forward, IMARC Group expects the market value to reach US$ 24.4 Billion by 2032, exhibiting a CAGR of 13.4% during the forecast period (2024-2032). View Report TOC, Figures and Tables : https://www.imarcgroup.com/wearable-injectors-market

5. Report Segmentation Breakup by Type: On-body Off-body   Breakup by Technology: Spring-based Motor-driven Rotary Pump Expanding Battery Others Breakup by Application: Oncology Infectious Diseases Cardiovascular Diseases

6. Report Segmentation Autoimmune Diseases Others Breakup by End Use: Hospitals and Clinics Home Care Others Breakup by Region: North America Asia-Pacific Europe Latin America Middle East and Africa

7. Competitive Landscape with Key Players Becton Dickinson and Company CeQur SA Debiotech SA Dexcom Inc. Enable Injections Inc. Gerresheimer AG Insulet Corporation Tandem Diabetes Care Inc. West Pharmaceutical Services Inc. Ypsomed AG.

8. Key Questions Answered in the Report

9. Key Questions Answered in the Report

10. Table of Contents 1    Preface 2    Scope and Methodology     2.1    Objectives of the Study     2.2    Stakeholders     2.3    Data Sources         2.3.1    Primary Sources         2.3.2    Secondary Sources     2.4    Market Estimation         2.4.1    Bottom-Up Approach         2.4.2    Top-Down Approach     2.5    Forecasting Methodology 3    Executive Summary 4    Introduction     4.1    Overview     4.2    Key Industry Trends 5    Global Wearable Injectors Market     5.1    Market Overview     5.2    Market Performance     5.3    Impact of COVID-19   5.4    Market Forecast 6     Market Breakup by Type 6.1 On-body 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Off-body 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Technology 7.1 Spring-based 7.1.1 Market Trends 7.1.2 Market Forecast        

11. Table of Contents 7.2 Motor-driven 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Rotary Pump 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Expanding Battery 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by Application 8.1 Oncology 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Infectious Diseases 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Cardiovascular Diseases 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Autoimmune Diseases 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast For more information, visit : https://www.imarcgroup.com/wearable-injectors-market/toc

12. Partial List of Clients

13. Partial List of Clients

14. Disclaimer © 2024 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

15. Contact Us Visit us at : https://www.imarcgroup.com [phone] [email protected] Stay With Us: